MedTrace Logo

Airvo/Optiflow High Flow Nasal Oxygenation During Microlaryngeal Surgery

NCT02780518 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-05-01

No results posted yet for this study

Summary

Optiflow high flow nasal cannula (HFNC) oxygenation is a technique to provide oxygen to patients when they are paralysed under general anaesthesia. Their lungs are not moving, but the high flow allows oxygen to travel into their lungs. This is called 'apnoeic ventilation'. The investigators will be using this for patients undergoing surgery for their throat.

Conditions

  • Throat Disorders

Interventions

DEVICE

Airvo

Applying high flow nasal oxygen

Sponsors & Collaborators

  • Singapore General Hospital

    lead OTHER

Principal Investigators

  • Patrick Wong, MBBS FRCA · Singapore General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02780518 on ClinicalTrials.gov